Posard Matthew L.

Halozyme Therapeutics, Inc. · Director

Posard Matthew L. is listed in public filings as director. This Posard Matthew L. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Halozyme Therapeutics, Inc. (HALO), and Nautilus Biotechnology, Inc. (NAUT). Investors use Posard Matthew L.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Halozyme Therapeutics, Inc.HALO$398k6k sharesGrant / ExerciseMay 5, 2026$397.9K6k shares$65.87--
Halozyme Therapeutics, Inc.HALO--77.8k sharesGrant / ExerciseMay 5, 2026Disclosure amount unavailable3.8k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Nautilus Biotechnology, Inc.NAUT$31k45k sharesGrant / ExerciseJun 23, 2025$31.3K45k shares$0.6951--
Halozyme Therapeutics, Inc.HALO$345k5.8k sharesGrant / ExerciseMay 1, 2025$345.2K5.8k shares$60.03--
Halozyme Therapeutics, Inc.HALO--74k sharesGrant / ExerciseMay 1, 2025Disclosure amount unavailable4.2k shares----
Nautilus Biotechnology, Inc.NAUT$115k45k sharesGrant / ExerciseJun 14, 2024$115.2K45k shares$2.56--